We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00760734
First Posted: September 26, 2008
Last Update Posted: April 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Semper Fi Fund
Marine Corps Law Enforcement Foundation
Coalition to Support America's Heroes
Thirty-eight other contributors
Information provided by (Responsible Party):
Paul G. Harch, M.D., Louisiana State University Health Sciences Center in New Orleans
  Purpose
This is a pilot trial to see if one or two 40 treatment courses of low pressure hyperbaric oxygen therapy can improve cognition and brain imaging in subjects with either chronic mild-moderate traumatic brain injury (TBI), also known as post-concussion syndrome (PCS) or chronic PCS with post-traumatic stress disorder (PTSD) secondary to blast injury.

Condition Intervention Phase
TBI (Traumatic Brain Injury) Post Concussion Syndrome Post Traumatic Stress Disorder Chronic Post Traumatic Stress Disorder Drug: Low pressure hyperbaric oxygen therapy Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: HBOT in Chronic Traumatic Brain Injury/Post Concussion Syndrome and TBI/PTSD Pilot Trial

Resource links provided by NLM:


Further study details as provided by Paul G. Harch, M.D., Louisiana State University Health Sciences Center in New Orleans:

Primary Outcome Measures:
  • Psychometric testing [ Time Frame: 30 days ]

Secondary Outcome Measures:
  • SPECT brain imaging [ Time Frame: 30 days ]
  • Quality of life measurements [ Time Frame: 30 days ]
  • Return to school or work [ Time Frame: 6 months ]

Enrollment: 30
Study Start Date: September 2008
Study Completion Date: June 2011
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Hyperbaric oxygen therapy-TBI/PCS
Intervention: Low pressure hyperbaric oxygen therapy, 40 or 80 twice daily, 5d/week, HBOTs at 1.5 ATA/60 minutes each. One month no treatment period between the 40th and 41st HBOT
Drug: Low pressure hyperbaric oxygen therapy
HBOT at 1.5 ATA/60 minutes twice/day, five days/week for 40 or 80 treatments
Other Name: HBOT
Drug: Low pressure hyperbaric oxygen therapy
HBOT: 1.5 ATA/60 minutes twice/day, 5 days/week for 40 or 80 treatments
Other Name: HBOT
Experimental: Hyperbaric Oxygen Therapy-PCS/PTSD
Intervention: Low pressure hyperbaric oxygen therapy, 40 or 80 twice daily, 5d/week, HBOTs at 1.5 ATA/60 minutes each. One month no treatment period between the 40th and 41st HBOT
Drug: Low pressure hyperbaric oxygen therapy
HBOT at 1.5 ATA/60 minutes twice/day, five days/week for 40 or 80 treatments
Other Name: HBOT
Drug: Low pressure hyperbaric oxygen therapy
HBOT: 1.5 ATA/60 minutes twice/day, 5 days/week for 40 or 80 treatments
Other Name: HBOT

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults, 18-65 years old
  • One or more mild-moderate TBI's characterized by loss of consciousness due to blast injury that is a minimum of one year old and occurred after 9/11/2001
  • Absence of acute cardiac arrest or hemorrhagic shock at time of TBI.
  • Absence of intracranial neurosurgery post-TBI
  • Disability Rating Scale of 0-3
  • Negative Michigan Alcohol Screening Test (MAST)
  • Negative Drug Abuse Screening Test (DAST)
  • Negative urine toxicology screen for drugs of abuse
  • Negative pregnancy test in females
  • Otherwise good health
  • Less than 90% on the Percent Back to Normal Rating Scale

Exclusion Criteria:

  • Pulmonary disease that precludes HBOT
  • Unstable medical conditions that are contraindicated in HBOT
  • Severe confinement anxiety
  • Pregnancy
  • Other pre-TBI neurological diagnoses
  • Pre or post TBI history of substance abuse
  • Pre or post TBI history of alcoholism.
  • Participation in another experimental trial with active intervention.
  • High probability of inability to complete the experimental protocol.
  • Previous HBOT
  • History of hospitalization for past TBI, stroke, nonfebrile seizures, or any seizure history other than seizure at the time of TBI
  • Past or current history of mental retardation (baseline FSIQ < 71.
  • Pre/post-TBI history of systemic illness with impact on CNS (P.I.'s decision)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00760734


Locations
United States, Louisiana
LSU Health Sciences Center
New Orleans, Louisiana, United States, 70112
Sponsors and Collaborators
Paul G. Harch, M.D.
Semper Fi Fund
Marine Corps Law Enforcement Foundation
Coalition to Support America's Heroes
Thirty-eight other contributors
Investigators
Principal Investigator: Paul G Harch, M.D. Louisiana State University Health Sciences Center in New Orleans
  More Information

Additional Information:
Publications:
Responsible Party: Paul G. Harch, M.D., Clinical Professor of Medicine, Louisiana State University Health Sciences Center in New Orleans
ClinicalTrials.gov Identifier: NCT00760734     History of Changes
Other Study ID Numbers: LSU IRB #7051
First Submitted: September 25, 2008
First Posted: September 26, 2008
Last Update Posted: April 18, 2017
Last Verified: April 2017

Keywords provided by Paul G. Harch, M.D., Louisiana State University Health Sciences Center in New Orleans:
Chronic traumatic brain injury
Post concussion syndrome
Post traumatic stress disorder
Chronic post traumatic stress disorder

Additional relevant MeSH terms:
Disease
Syndrome
Wounds and Injuries
Brain Injuries
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Post-Concussion Syndrome
Pathologic Processes
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Trauma and Stressor Related Disorders
Mental Disorders
Brain Concussion
Head Injuries, Closed
Wounds, Nonpenetrating